ArticleGlobal heart2025
Association of Female Reproductive Factors with Incident Cardiometabolic Disease: Finding from a European Population-Based Study.
Article in Global heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiometabolic diseases (CMD), including ischemic heart disease, stroke, and type 2 diabetes, have caused an enormous global healthcare burden. Beyond traditional risk factors, female reproductive factors may also be associated with CMD. However, comprehensive evaluations of female reproductive factors related CMD is limited. Methods: A total of 189,411 women with no prior CMD from the UK Biobank cohort from 2007 to 2010 were included and followed until December 2022. Associations between reproductive factors and CMD were analyzed using Cox proportional hazards models with adjustment for potential confounders based on the directed acyclic graph (DAG). Results: During a median follow-up of 13.2 years, 17,251 incident CMD events occurred. Compared to menarche at age 12-13 years, <12 years and >13 years had a higher risk of CMD (HR <12 year (y) vs 12-13 y: 1.04 [95% CI, 1.01-1.08]; >13 y vs 12-13 y: 1.08 [1.04-1.13]). Earlier age at menopause was related to a higher risk of CMD (HR <46 y vs 50-51 y: 1.22 [1.15-1.29]; 46-49 y vs 50-51 y: 1.08 [1.03-1.14]), and a short reproductive lifespan (HR <33 y vs 36-38 y: 1.19 [1.13-1.25]; 33-35 y vs 36-38 y: 1.08 [1.03-1.14]). Younger age at first live birth (HR <22 y vs 24-26 y: 1.18 [1.12-1.24]; 22-23 y vs 24-26 y: 1.06 [1.00-1.12]) and last live birth (HR <26 y vs 29-30 y: 1.12 [1.06-1.18]) were associated with higher risk. Women with three or four children (HR 3-4 children: 1.21 [1.15-1.28]) and those with more than four children (HR >4 children: 1.27 [1.07-1.52]) were associated with higher risk of CMD. Recurrent pregnancy loss was associated with a 39% and 14% higher risk of CMD, respectively. Conclusion: Female reproductive factors are associated with CMD, independent of traditional risk factors. These reproductive factors could inform clinical screening and improve cardiometabolic risk assessment in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.